FDA alerts providers to lack of sterility in NuVision Pharmacy products

Share this article:

The Food and Drug Administration expanded an alert about NuVision Pharmacy of Dallas, TX, on Saturday. It said investigators found poor sterile production practices that raised concern about a lack of sterility assurance for the company's sterile drug products.

NuVision recalled methylcobalamin injection (a form of Vitamin B12 injection) and lyophilized injection (freeze-dried powder) products in April because of a lack of sterility assurance and problems with quality control processes. Microbial contamination in a drug product can put a patient or resident at a serious infection risk, the FDA said.

Healthcare providers should check their medical supplies for NuVision sterile products, quarantine them and not give them to patients or residents, the FDA warned. Providers and consumers should report adverse reactions or problems to MedWatch

Share this article:
close

Next Article in Products

More in Products

Last day to enter McKnight's Tech Awards

Today is the final day to submit entries into the third annual McKnight's Excellence in Technology Awards.

AliMed offers three new fall management products

AliMed offers three new fall management products

AliMed is now offering the AliMed CordLess® Sensor Alarm and the AliMed Worry-Free Fall Alarm to help reduce the risk of accidental falls, and the HipShield® X-tra to help prevent ...

Diamond Wipes creates new wipes

Diamond Wipes creates new wipes

Diamond Wipes has announced an updated version of its Handyclean™ cleaning and sanitizing wipes.